The Crucial Role of Psychologists in End-of-Life Care and Voluntary Assisted Dying in Australia

New research highlights the vital role psychologists could play in supporting end-of-life and voluntary assisted dying in Australia, addressing current barriers and policy gaps.
Psychologists have the potential to be vital contributors to end-of-life care, especially in the context of Australia's growing adoption of voluntary assisted dying (VAD). Recent research from Edith Cowan University highlights significant barriers that currently hinder their involvement. The study, led by Master's student Dr. Vivienne Heng and Associate Professor Eyal Gringart, is among the first to explore the perspectives of Provisionally Registered Psychologists (PRPs) on VAD. Published in the journal OMEGA—Journal of Death and Dying, it emphasizes the importance of understanding psychological support needs during this sensitive process.
In-depth interviews with 20 PRPs revealed that while they support VAD for terminally ill patients and see its potential for individuals with dementia, many are reluctant to engage due to various obstacles. These include emotional stress, fear of legal consequences, insufficient education and professional exposure, unclear legal and ethical guidelines, and inadequate compensation. An additional significant deterrent is the 'gag clause,' which restricts health professionals from discussing VAD topics openly. Although some states, like Victoria, are proposing amendments to repeal this clause, its current presence remains a barrier.
As all Australian states and the ACT have legalized VAD, with the NT currently in consultation, the demand for mental health support at end-of-life is increasing. An aging population and the rising prevalence of chronic illnesses contribute to this need. Despite this, psychologists—experts in assessing mental capacity, supporting patients and families emotionally, and providing grief counseling—are seldom involved in the VAD process, with only about 1% reporting expertise in palliative care.
The research calls for curriculum reforms in psychology training across Australia to better prepare future psychologists for roles in end-of-life care, especially as laws and practices around VAD continue to evolve. Historically less engaged with older adults, psychologists' involvement could significantly improve holistic care, addressing mental health, grief, and community education.
Psychologists' skills are well-suited for supporting patients, families, and healthcare professionals through mental health assessments, grief counseling, and capacity evaluations during VAD. Dr. Heng emphasizes that this is not merely about assessing mental capacity but about providing compassionate, inclusive, and evidence-based care during the profound life-and-death decisions facing patients today.
Source: https://medicalxpress.com/news/2025-08-life-key-player-psychologist.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Pancreatic Cancer Treatment Targets Newly Discovered Protein
Researchers develop a groundbreaking treatment targeting a newly identified protein in pancreatic cancer, showing promising results in preclinical studies to combat this deadly disease.
Decade-Long Study Shows Radiation Therapy Equal in Effectiveness to Surgery for Early-Stage Non-Small Cell Lung Cancer
A 10-year study reveals that stereotactic radiation therapy offers survival rates similar to surgery for early-stage non-small cell lung cancer, with fewer side effects and improved quality of life.
Study Finds Comparable Outcomes for Intensity-Modulated Radiation Therapy and Proton Therapy in Oropharyngeal Cancer
A groundbreaking clinical trial shows that intensity-modulated radiation therapy (IMRT) and proton therapy produce similar quality-of-life outcomes and low side effect rates in treating oropharyngeal cancer, affirming IMRT as an effective and accessible treatment option.
Emerging Epigenetic Biomarkers Enhance Prediction of Cardiovascular Disease Risk
New epigenetic biomarkers identified in recent research could revolutionize cardiovascular disease risk prediction and early diagnosis, offering personalized approaches to prevention and treatment.



